
    
      This study will involve about 8 visits over 1Â½ years .Each participant will be enrolled in
      study as per inclusion and exclusion criteria .Informed consent will be taken from subject
      before including in study. Subject will be underwent for specific tests of the participant's
      vision and health. These visits may include visual exams, blood draw for laboratory testing,
      brief medical history and exam, and occasionally a questionnaire (survey), in addition to the
      visit for the surgical procedures. The primary outcome for this study will be a visual acuity
      score after one year of stem cell therapy .

      Follow-up visits will be required regularly to determine the effectiveness of Autologous Bone
      Marrow derived Mono Nuclear Stem Cell (BMMNCs) in RP.
    
  